ICON And Medable Drive 85% eConsent Adoption In U.S. Menopause Study

Achieving strong electronic consent adoption can be difficult in complex clinical trials — especially those with frequent assessments and diverse participant populations. A U.S.-based menopause study demonstrates how a coordinated, site-first approach can drive meaningful results. Working in partnership, ICON and Medable supported a women’s health trial enrolling more than 1,200 participants across 18 sites, many of whom faced a demanding schedule of repeated digital assessments.

By simplifying training, tailoring onboarding materials to site needs, and deploying hands-on concierge support, sites were equipped to confidently introduce electronic consent to participants in both English and Spanish. Clinical Research Associates were also enabled with consistent resources, reinforcing adoption at the site level. The outcome was an 85%+ electronic consent adoption rate, full compliance with digital workflows, and strong enrollment performance at high-volume sites.

The experience highlights how thoughtful change management, CRO collaboration, and practical site enablement can reduce friction, improve participant onboarding, and support adherence in trials with complex protocols. Read the full case study to explore strategies that can strengthen eConsent adoption in future studies.